Van Cleef Asset Management,Inc
Source: SEC Form 13F · as of Mar 2026Van Cleef Asset Management,Inc holds 10 biotech & pharma companies tracked by BioSniper, totaling $15.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$15.2M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 16,793 | $4.1M |
| LLYELI LILLY & Co | 2,786 | $2.6M |
| MRKMerck & Co., Inc. | 19,008 | $2.3M |
| ABBVAbbVie Inc. | 7,454 | $1.6M |
| PFEPFIZER INC | 44,347 | $1.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,054 | $1.1M |
| GILDGILEAD SCIENCES, INC. | 4,950 | $690K |
| AMGNAMGEN INC | 1,572 | $553K |
| BMYBRISTOL MYERS SQUIBB CO | 8,937 | $542K |
| ABTABBOTT LABORATORIES | 5,090 | $523K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.